Renascience

4889.TPharmaceutical

Filed as Renascience, Inc (2022-06–2022-06)

Key numbers · FY ended 2026-03

Operating income−¥357m—Total assets¥3.5bn+87.2% YoY EPS (basic)¥-23.39-362.2% YoY

Full financial history and reports →

Stock price4889 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Jun 16 · JST1 filing

15:355% STAKERenascience · DCI Partners Co., Ltd. · 5.76% → 4.59%−1.17pp

Mon, Feb 3 · JST1 filing

15:545% STAKERenascience · DCI Partners Co., Ltd. · 6.83% → 5.76%−1.07pp

Wed, Jan 22 · JST1 filing

15:475% STAKERenascience · DCI Partners Co., Ltd. · 8.73% → 6.83%−1.90pp

Tue, Jan 21 · JST1 filing

16:065% STAKERenascience · DCI Partners Co., Ltd. · 10.22% → 8.73%−1.49pp

Fri, Dec 20 · JST1 filing

14:365% STAKERenascience · Toshio Miyata · 22.97% → 21.53%−1.44pp

All filings →

Major holders (5%+) · 2

Holder	Stake	Change	Filed
Toshio Miyata	21.07%	-0.46pp	2025-12-19
Heights Capital Management, Inc.	6.65%	0.00pp	2026-03-12

Each holder's own ratio from its most recent large-shareholding report.